ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 89 filers reported holding ERASCA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,843,668 | -27.5% | 7,027,243 | +1.6% | 0.00% | -100.0% |
| Q2 2023 | $19,091,345 | +18.1% | 6,917,154 | +28.8% | 0.00% | – |
| Q1 2023 | $16,169,265 | -24.9% | 5,371,849 | +7.6% | 0.00% | -100.0% |
| Q4 2022 | $21,522,188 | -42.4% | 4,993,547 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $37,345,000 | +57.7% | 4,787,793 | +12.6% | 0.00% | 0.0% |
| Q2 2022 | $23,687,000 | -28.5% | 4,252,373 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $33,114,000 | +12.5% | 3,850,410 | +103.9% | 0.00% | 0.0% |
| Q4 2021 | $29,422,000 | +14.7% | 1,888,445 | +56.2% | 0.00% | 0.0% |
| Q3 2021 | $25,651,000 | – | 1,208,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |